Plaintiffs Blame Zantac For Causing Colon Cancer
Online testing pharmacy Valisure found NDMA levels thousands of times higher than the level the FDA deemed safe
Monday, September 14, 2020 - Colon cancer is the second most deadly form of cancer and one of the most feared of all diseases. About one-third of colorectal-cancer victims die within five years of diagnosis. Only lung cancer is more deadly. You might consider speaking with a Zantac Colon Cancer Lawyer to see if you qualify to file a claim for monetary reimbursements and lump-sum damages if you or a loved one have been diagnosed with colon cancer and have used Zantac.
People with colon cancer have filed lawsuits against Sanofi, the maker of Zantac, for failing to warn them that the world's best-selling heartburn and acid reflux medicine allegedly cause their disease. Colon cancer joins a long list of cancer that may be caused by using Zantac like stomach cancer, bladder, esophagus, prostate, and breast cancer, and many others. The symptoms of cancer may not be apparent for over a decade; people should see a doctor if they used Zantac for more than a year. Early detection of colon cancer is the key to treating the condition successfully.
Pittsburgh Legal Examiner (PLE) reports that a California man who recently filed a lawsuit accusing taking Zantac for nearly a decade caused him to develop colon cancer. "According to his complaint, the plaintiff started using prescription Zantac (ranitidine) in 2000. The plaintiff was diagnosed with colon cancer in May of 2008, . He blames his cancer on his Zantac use and states that had he known Zantac could lead to exposure to N-nitrosodimethylamine (NDMA), he never would have taken it," PLE tells readers. Lawsuits like this alleged that the drug manufacturers are obligated to warn consumers of what they knew or should have known about high levels of NDMA in ranitidine medicine developing from sitting on store shelves at high temperatures. Online testing pharmacy Valisure found NDMA levels thousands of times higher than the level the FDA deemed safe and reported their findings to the FDA in 2019. Sanofi recalled Zantac immediately, and the FDA followed suit about a month later. Elevated levels of NDMA are in blood pressure medicine and diabetes drugs also. NDMA is a carcinogen compound found in most foods we eat in levels thought to be safe. NDMA is used to induce cancer tumors in laboratory test animals.
The Zantac California colon cancer lawsuit points to a study published by the National Institute of Health (NIH) showing elevated levels of NDMA, a potent carcinogen, in the urine of test subjects that ingested ranitidine. According to the NIH paper, "(the study suggests) evaluated the urinary NDMA excretion attributable to the ingestion of clinically used ranitidine doses. Urine samples collected from five female and five male, healthy adult volunteers over 24-h periods before and after consumption of 150mg ranitidine were analyzed for residual ranitidine, ranitidine metabolites, NDMA, total N-nitrosamines, and dimethylamine. Following ranitidine intake, the urinary NDMA excreted over 24h increased 400-folds from 110 to 47 600ng, while total N-nitrosamines increased 5-folds."
More Recent Heartburn MedicineLawsuit News:
- Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
- Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
- Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
- The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
- Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
- Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
- Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
- A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
- Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
- Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
- Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
- Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
- The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
- Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
- Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
- Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
- Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
- Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
- Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
- Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022
Lawyers for Zantac Heartburn Medicine Lawsuits
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.